http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022076847-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7975a1f3a879b077d416a3dff6d9623
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H40-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-10
filingDate 2021-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af8dc7479f4280d61a3b7a11a74d00e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6947b59f27711de361f99f32475a336d
publicationDate 2022-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2022076847-A1
titleOfInvention Database and machine learning in response to parallel serial dual microfluidic chip
abstract A microfluidic chip device includes a reservoir for holding a biologic sample containing a predetermined biologic material. A first plurality of parallel pathways each testing one of one or more treatment-agents and analyzing a first efficacy for each of the one or more treatment agents applied to the predetermined biologic material within the biologic sample. A multiplexer provides a portion of the biologic sample into each of the first plurality of parallel pathways from the reservoir. A second plurality of parallel pathways each test a plurality of different dosage levels of the one or more treatment agents and analyzes a second efficacy of the plurality of different dosage levels with respect to the predetermined biologic material. The multiplexer further provides a second portion of the biologic sample into a selected at least one of the second plurality of parallel pathways responsive to a control input indicating the treatment agent providing a highest efficacy.
priorityDate 2017-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92323602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482240
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409702108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323431
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507616

Total number of triples: 33.